Summit Wealth Group (Colorado)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$283K Buy
5,867
+875
+18% +$44.7K 0.02% 359
2026
Q2
$262K Buy
4,992
+569
+13% +$30.1K 0.02% 328
2026
Q1
$244K Buy
4,423
+144
+3% +$7.8K 0.03% 294
2025
Q4
$210K Buy
+4,279
New +$200K 0.03% 263

Other funds holding GSK

Summit Wealth Group (Colorado)'s GSK Position: Q3 2026 in Review

Summit Wealth Group (Colorado) increased its GSK (GSK) stake by 18% in Q3 2026, buying an estimated $44.7K and bringing the position to 5,867 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #359.

Summit Wealth Group (Colorado) first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. 992 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Summit Wealth Group (Colorado) held 5,867 shares of GSK worth $283K as of Q3 2026.
  • Summit Wealth Group (Colorado) bought 875 GSK shares in Q3 2026, an estimated $44.7K.
  • GSK made up 0.02% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #359 holding.
  • Summit Wealth Group (Colorado) first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • 992 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.